Article:
Association of Laboratory Parameters with Clinical Outcomes of SARS-CoV-2 Patients

creativeworkseries.issn1999-6217
dc.contributor.authorNeupane, Mamata Sharma
dc.contributor.authorHassan, Hafizah Che
dc.contributor.authorUranw, Surendra Kumar
dc.contributor.authorMehta, Raj Kumar
dc.date.accessioned2026-08-20T04:03:49Z
dc.date.available2026-08-20T04:03:49Z
dc.date.issued2026
dc.descriptionMamata Sharma Neupane Lincoln University College, Malaysia Hafizah Che Hassan Lincoln University College, Malaysia https://orcid.org/0000-0001-7292-4315 Surendra Kumar Uranw B.P.Koirala Institute of Health Sciences, Nepal https://orcid.org/0000-0002-1471-8318 Raj Kumar Mehta Chitwan Medical College, Bharatpur, Nepal https://orcid.org/0000-0002-1241-8119
dc.description.abstractAbstract: Background: The COVID-19 pandemic has imposed a significant burden on healthcare systems, particularly in resource-limited settings. Laboratory biomarkers may help predict disease outcomes and guide clinical decisions. However, there is limited evidence from Nepal regarding the prognostic value of these markers among hospitalized COVID-19 patients. Methods: A hospital-based observational study was conducted among 348 RT-PCR–confirmed COVID-19 patients admitted to the COVID ICUs and wards of a tertiary care hospital in Nepal between March 2022 and June 2023. Data on sociodemographic characteristics, haematological parameters, liver and inflammatory markers, urine microscopy, and SARS-CoV-2 molecular gene markers were collected prospectively. Clinical outcomes were categorized as survived or died. Descriptive statistics, chi-square tests, and binary logistic regression were used to analyse associations and identify predictors of mortality. Results: Out of the total 348 patients included in the study, 71 patients (20.4%) died, while 277 patients (79.6%) survived. Among 348 patients, significant associations with mortality were observed for lymphopenia (p = .001), neutrophilia (p < .001), elevated ALT (p < .001), elevated AST (p = .001), and positive D-dimer (p < .001). High viral load (Ct value ?20) for E, N, and ORF1ab ab genes was also significantly associated with mortality in univariate analysis. Logistic regression identified D-dimer positivity (OR = 0.027, p = .001) and elevated ALT (OR = 0.356, p = .016) as independent predictors of mortality. Conclusions: Laboratory parameters, especially lymphocyte count, D-dimer, and ALT levels, are valuable prognostic indicators of clinical outcomes in hospitalized COVID-19 patients. Integrating these markers into clinical assessment may enhance early risk stratification and resource allocation. Keywords: Biomarkers; C-Reactive protein; COVID-19; critical care; d-dimer.
dc.identifierhttps://doi.org/10.33314/jnhrc.v24i01.5358
dc.identifier.urihttps://hdl.handle.net/20.500.14572/7369
dc.language.isoen_US
dc.publisherNepal Health Research Council
dc.subjectBiomarkers
dc.subjectC-Reactive protein
dc.subjectCOVID-19
dc.subjectcritical care
dc.subjectd-dimer
dc.titleAssociation of Laboratory Parameters with Clinical Outcomes of SARS-CoV-2 Patients
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
oaire.citation.endPage166
oaire.citation.startPage159
relation.isJournalIssueOfPublicationa1c63b20-6d6e-4473-9408-632d1b427f81
relation.isJournalIssueOfPublication.latestForDiscoverya1c63b20-6d6e-4473-9408-632d1b427f81
relation.isJournalOfPublication40bd2739-8b19-447c-be60-723a1bdd1dcd

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
159-166.pdf
Size:
302.89 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections